Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma - Prasopporn, Sunisa; Suppramote, Orawan; Ponvilawan, Ben; Jamyuang, Chanette; Chanthercrob, Jantappapa; Chaiboonchoe, Amphun; More-Krong, Pimkanya; Kongsri, Kamonchanok; Suntiparpluacha, Monthira; Chanwat, Rawisak; Korphaisarn, Krittiya; Okada, Seiji; et al. (Frontiers in Oncology, 2023)